Immunostimulatory nucleic acids
US7271156B2 · kind B2 · utility
Assignees
Inventors
Key dates
| Filing date | Dec 9, 2002 |
| Grant date | Sep 18, 2007 |
| Priority date | — |
| Expiry date | Dec 9, 2022 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/55561
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to immunostimulatory nucleic acid compositions and methods of using the compositions. The T-rich nucleic acids contain poly T sequences and/or have greater than 25% T nucleotide residues. The TG nucleic acids have TG dinucleotides. The C-rich nucleic acids have at least one poly-C region and/ore greater than 50% c nucleotides. These immunostimulatory nucleic acids function in a similar manner to nucleic acids containing CpG motifs. The invention also encompasses preferred CpG nucleic acids.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.